Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications.

Keyphrases

• Attendants 33%
• Bleeding 66%
• Budd-Chiari Syndrome 33%
• Child Class 66%
• Cirrhotic Patients 33%
• Community Hospital 33%
• Community University 33%
• Complications of Portal Hypertension 33%
• Hepatic Encephalopathy 33%
• Hepatic Hydrothorax 33%
• Highly Effective 33%
• Hospital Center 33%
• Liver Failure 33%
• Liver Transplantation 100%
• Local Anesthesia 33%
• Nonoperative 33%
• Portal Hypertension 100%
• Portal Hypertensive Gastropathy 33%
• Postoperative Mortality 33%
• Recurring 33%
• Refractory Ascites 33%
• Refractory Variceal Bleeding 33%
• Sclerotherapy 33%
• Shunt 66%
• Surgical Shunt 33%
• Transjugular Intrahepatic Portosystemic Shunt 100%
• Transplantation 33%
• Treatment Complications 33%
• Treatment Course 33%
• United States 33%
• University Centers 33%
• Variceal Hemorrhage 66%
• Variceal Ligation 33%

Medicine and Dentistry

• Ascites 25%
• Bleeding 75%
• Budd-Chiari Syndrome 25%
• Complication of Treatment 25%
• Contraindication 100%
• Hemodynamic 25%
• Hepatic Encephalopathy 25%
• Hydrothorax 25%
• Ligation 25%
• Liver Failure 25%
• Liver Transplantation 75%
• Local Anesthesia 25%
• Portal Hypertension 100%
• Sclerotherapy 25%
• Shunting 25%
• Stomach Disease 25%
• Transjugular Intrahepatic Portosystemic Shunt 100%